Volume 14, issue 4, August 2012
36 articles in this issue
-
-
-
-
-
New methods in mammary gland development and cancer: proteomics, epigenetics, symmetric division and metastasis
Authors (first, second and last of 4)
-
The interaction between ER and NFκB in resistance to endocrine therapy
Authors (first, second and last of 8)
-
-
-
-
-
-
Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk
Authors (first, second and last of 10)
-
Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification
Authors (first, second and last of 7)
-
Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer
Authors (first, second and last of 14)
-
Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways
Authors (first, second and last of 10)
-
Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met
Authors (first, second and last of 6)
-
Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions
Authors (first, second and last of 10)
-
CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations
Authors (first, second and last of 9)
-
Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells
Authors (first, second and last of 6)
-
-
Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
Authors (first, second and last of 9)
-
-
-
Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer
Authors (first, second and last of 12)
-
The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition
Authors (first, second and last of 6)
-
Height, adiposity and body fat distribution and breast density in young women
Authors (first, second and last of 15)
-
Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer
Authors (first, second and last of 12)
-
Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival
Authors (first, second and last of 13)
-
High-throughput mammographic-density measurement: a tool for risk prediction of breast cancer
Authors (first, second and last of 8)
-
FGFR1 is amplified during the progression of in situto invasive breast carcinoma
Authors (first, second and last of 10)
-
Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis
Authors (first, second and last of 7)
-
Tumour morphology of early-onset breast cancers predicts breast cancer risk for first-degree relatives: the Australian Breast Cancer Family Registry
Authors (first, second and last of 6)
-
A single proteolytic cleavage within the lower hinge of trastuzumab reduces immune effector function and in vivo efficacy
Authors (first, second and last of 11)
-
Prognostic impact of circulating tumor cells assessed with the CellSearch Systemâ„¢ and AdnaTest Breastâ„¢ in metastatic breast cancer patients: the DETECT study
Authors (first, second and last of 10)
-
Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain
Authors (first, second and last of 17)
-
Gene-expression profiling of microdissected breast cancer microvasculature identifies distinct tumor vascular subtypes
Authors (first, second and last of 10)
